Entero Healthcare Solutions Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/08/2026 ,inter alia, to consider and approve the Unaudited Standalone ....

Ref: 25/SE/LC/2026-27 Date: July 28, 2026 Scrip Code BSE: 544122 NSE: ENTERO ISIN: INE010601016 Head, Listing Compliance Department Head, Listing Compliance Department BSE Limited National Stock Exchange of India Limited Phiroze Jeejeebhoy Towers Dalal Street, Exchange Plaza, Plot No. C/1. G Block, Mumbai - 400 001 Bandra -Kurla Complex, Bandra (East), Mumbai- 400 051 Dear Sir/Madam, Sub: Intimation of Notice of Board Meeting Pursuant to Regulation 29 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform that a meeting of the Board of Directors of the Company is scheduled to be held on Friday, August 07, 2026, inter-alia, to consider, approve and take on record the Unaudited Standalone and Consolidated Financial Results (along with Limited Review Report) for the quarter ended June 30, 2026. As informed vide our letter dated June 23, 2026, the trading window for dealing in the securities of the Company is closed for all designated persons and their immediate relatives with e(cid:431)ect from July 01, 2026, and will continue to remain closed till completion of 48 hours after declaration of aforesaid results unless communicated otherwise. This is for your information and records. Yours Faithfully For Entero Healthcare Solutions Limited Sanu Kapoor Vice President- Group General Counsel, Company Secretary & Compliance Officer